Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,568 INR | -3.80% | -2.70% | +3.57% |
Apr. 25 | India's Coromandel International posts 35% fall in Q4 profit on soft agrochemical demand | RE |
Mar. 31 | SRF Limited Announces Cessation of Independent Directors | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- With an expected P/E ratio at 56.52 and 39.38 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.57% | 9.48B | - | ||
+1.22% | 77.72B | B | ||
+0.91% | 32.51B | C | ||
+8.75% | 18.21B | B | ||
-9.28% | 11.6B | B | ||
+8.69% | 11.28B | A- | ||
-2.33% | 9.94B | - | ||
+5.97% | 9.92B | A- | ||
+4.24% | 8.33B | B | ||
+0.15% | 6.59B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SRF Stock
- SRF Stock
- Ratings SRF Limited